Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behaviour in rats

Psychopharmacology

Volumn 150, Issue 4, 2000, Pages 422-429

  Wadenberg, Marie Louise G ^a   Kapur, Shitij ^a,b   Soliman, Alexandra ^a   Jones, Corey ^a   Vaccarino, Franco ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

11C Raclopride; 3H Rachlopride; Catalepsy; Conditioned avoidance response; D2 receptor occupancy; In vivo; Rat

Indexed keywords

DOPAMINE 2 RECEPTOR; RACLOPRIDE; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CATALEPSY; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; EXTRAPYRAMIDAL SYMPTOM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; ANIMAL; CHEMICALLY INDUCED DISORDER; CONDITIONING; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; AVOIDANCE LEARNING; CATALEPSY; CONDITIONING (PSYCHOLOGY); DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2;

EID: 0033624208     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000466     Document Type: Article

References (39)

1. Ahlenius S, Hillegaart V (1986) Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre-and postsynaptic inhibition of dopaminergic neurotransmission. Pharmacol Biochem Behav 24:1409-1415
2. Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics. Pergamon Press, New York, pp 383-435
3. Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-203
4. 2 receptor blocker, in acute schizophrenia: an open trial. Int Clin Psychopharmacol 4:61-70
5. Cherry SR, Chatziioannou A, Annala AJ, Doshi NK, Phelps ME (1998) MicroPET - a dedicated high resolution PET scanner for animal imaging. Soc Neurosci 24:429
6. Elliott PJ, Close SP, Walsh DM, Hayes AG, Marriott AS (1990) Neuroleptic-induced catalepsy as a model of Parkinson's disease. I. Effect of dopaminergic agents. J Neural Transm 2:79-89
7. 2 dopamine receptor binding in the living human brain by PET. Science 231:258-261
8. 2-dopamine receptor occupancy in schizophrenia patients treated with antipsychotic drugs. Arch Gen Psychiatry 45:71-76
9. 2-dopamine receptor occupancy by PET. Psychopharmacology 94:1-7
10. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538-544
11. Heimer L, Alheid GF, Zahm DS (1993) Basal forebrain organization: an anatomical framework for motor aspects of drive and motivation. In: Kalivas PW, Barnes CD (eds) Limbic motor circuits and neuropsychiatry. CRC Press, Boca Raton, Fla., pp 1-43
12. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA (1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12:47-54
13. Ito H, Hietala J, Blomqvist G, Halldin C, Farde L (1998) Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [C-11]raclopride binding. J Cereb Blood Flow Metab 18:941-950
14. 2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. Life Sci 57:103-107
15. 2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 153:948-950
16. 2 receptor occupancy of clozapine, risperidone and olanzapine in schizophrenia: clinical and theoretical implications. Am J Psychiatry 156:286-293
17. 2 occupancy, clinical response and side effects - a double blind PET study in first episode schizophrenia. Am J Psychiatry 157:514-520
18. 2 receptors in the rat brain. Biochem Pharmacol 34:2251-2259
19. Kuschinsky K, Hornykiewicz O (1972) Morphine catalepsy in the rat; relation to striatal dopamine metabolism. Eur J Pharmacol 19:119-122
20. Li CC (1964) Introduction to experimental statistics. McGraw-Hill, New York, pp 207-226
21. Mijnster MJ, Schotte A, Docter GJ, Voorn P (1998) Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat. Synapse 28:302-312
22. Mogenson GJ, Jones DL, Yim CY (1980) From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14:69-97
23. 2-dopamine receptor occupancy in relation to antipsychotic drug effects - a double blind PET study of schizophrenic patients. Biol Psychiatry 33:227-235
24. Owens MJ, Risch SC (1995) Atypical antipsychotic s. In: Schatzberg AF, Nemeroff CB (eds) Psychopharmacology Press, Washington D.C., pp 263-280
25. Sanberg PR (1980) Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 284:472-473
26. Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel, P, Lesage AS, De Loore K, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo binding. Psychopharmacology 124:57-73
27. 4. Neuropsychopharmacology 7:261-284
28. 2 receptors, yet occupy high levels of these receptors. Mol Psychiatry 3:123-134
29. 2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry 156:876-884
30. 4 receptors. Neuropsychopharmacology 16:93-122
31. Siegel S, Castellan NJ Jr (1988) Nonparametric statistics for the behavioral sciences, 2nd edn. McGraw-Hill, New York
32. Swerdlow NR, Geyer MA (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24:285-301
33. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530-536
34. Varty GB, Higgins GA (1995) Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology 122:15-26
35. Wadenberg M-L (1996) Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev 20: 325-339
36. Wadenberg M-L, Hicks PB (1999) The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? Neurosci Biobehav Rev 23:851-862
37. Wadenberg M-L, Ericson E, Magnusson O, Ahlenius S (1990) Suppression of conditioned avoidance behavior by the local application of (-) sulpiride into the ventral, but not the dorsal, striatum of the rat. Biol Psychiatry 28:297-307
38. Wadenberg M-L, Ahlenius S, Svensson TH (1993) Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: implications for the mechanism of action of clozapine. Psychopharmacology 110:273-279
39. Wadenberg M-L, Young KA, Trompler RA, Zavodny RA, Richter TJ, Hicks PB (1998) A novel computer controlled conditioned avoidance apparatus for rats. J Pharmacol Toxicol Meth 38:211-215